Lamotrigine	lamotrigine	S_chemicals	O
associated	associated	O	O
with	with	O	O
exacerbation	exacerbation	O	O
or	or	O	O
de	de	O	O
novo	novo	S_chemicals	O
myoclonus	myoclonus	O	S_disease
in	in	O	O
idiopathic	idiopathic	O	O
generalized	generalized	O	B_disease
epilepsies	epilepsies	O	S_disease
.	.	O	O

Five	five	O	O
patients	patients	O	O
with	with	O	O
idiopathic	idiopathic	O	O
generalized	generalized	O	B_disease
epilepsies	epilepsies	O	S_disease
(	(	O	O
IGE	ige	S_chemicals	O
)	)	O	O
treated	treated	O	O
with	with	O	O
lamotrigine	lamotrigine	S_chemicals	O
(	(	O	O
LTG	ltg	O	O
)	)	O	O
experienced	experienced	O	O
exacerbation	exacerbation	O	O
or	or	O	O
de	de	O	O
novo	novo	S_chemicals	O
appearance	appearance	O	O
of	of	O	O
myoclonic	myoclonic	O	B_disease
jerks	jerks	O	I_disease
(	(	O	O
MJ	mj	O	O
)	)	O	O
.	.	O	O

In	in	O	O
three	three	O	O
patients	patients	O	O
,	,	O	O
LTG	ltg	O	O
exacerbated	exacerbated	O	O
MJ	mj	O	O
in	in	O	O
a	a	O	O
dose-dependent	dose-dependent	O	O
manner	manner	O	O
with	with	O	O
early	early	O	O
aggravation	aggravation	O	O
during	during	O	O
titration	titration	O	O
.	.	O	O

MJ	mj	O	O
disappeared	disappeared	O	O
when	when	O	O
LTG	ltg	O	O
dose	dose	O	O
was	was	O	O
decreased	decreased	O	O
by	by	O	O
25	25	O	O
to	to	O	O
50	50	O	O
%	%	O	O
.	.	O	O

In	in	O	O
two	two	O	O
patients	patients	O	O
,	,	O	O
LTG	ltg	O	O
exacerbated	exacerbated	O	O
MJ	mj	O	O
in	in	O	O
a	a	O	O
delayed	delayed	O	O
but	but	O	O
more	more	O	O
severe	severe	O	O
manner	manner	O	O
,	,	O	O
with	with	O	O
myoclonic	myoclonic	O	S_disease
status	status	O	O
that	that	O	O
only	only	O	O
ceased	ceased	O	O
after	after	O	O
LTG	ltg	O	O
withdrawal	withdrawal	O	O
.	.	O	O

